SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Outcome For Audited Financial Results.
Outcome of Board Meeting24-05-2024
SUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Outcome For Audited Financial Results.
Outcome of Board MeetingSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Board Meeting Intimation for Board Meeting For Announcement Of Audited Standalone And Consolidated Financial Results And Other Connected Matters
SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 ,inter alia, to consider and approve As attachedSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Investor's call on Vodobatinib Parkinson's Disease program held on April 15, 2024SPARC closes ongoing study on Parkinson's drug
Sun Pharma has reviewed the data from the PROSEEK study and determined that it has not shown evidence of treatment benefit in patients receiving VodobatinibSUN PHARMA ADVANCED RESEARCH COMPANY LTD. - 532872 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
SPARC Announcement Press Release